BQ788 reveals glial ET B receptor modulation of neuronal cholinergic and nitrergic pathways to inhibit intestinal motility: Linked to postoperative ileus

ET-1 signalling modulates intestinal motility and inflammation, but the role of ET-1/ET receptor signalling is poorly understood. Enteric glia modulate normal motility and inflammation. We investigated whether glial ET signalling regulates neural-motor pathways of intestinal motility and inflammatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 2023-10, Vol.180 (19), p.2550-2576
Hauptverfasser: Mazzotta, Elvio, Grants, Iveta, Villalobos-Hernandez, Egina, Chaudhuri, Samhita, McClain, Jonathon L, Seguella, Luisa, Kendig, Derek M, Blakeney, Bryan A, Murthy, Srinivasa K, Schneider, Reiner, Leven, Patrick, Wehner, Sven, Harzman, Alan, Grider, John R, Gulbransen, Brian D, Christofi, Fedias L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2576
container_issue 19
container_start_page 2550
container_title British journal of pharmacology
container_volume 180
creator Mazzotta, Elvio
Grants, Iveta
Villalobos-Hernandez, Egina
Chaudhuri, Samhita
McClain, Jonathon L
Seguella, Luisa
Kendig, Derek M
Blakeney, Bryan A
Murthy, Srinivasa K
Schneider, Reiner
Leven, Patrick
Wehner, Sven
Harzman, Alan
Grider, John R
Gulbransen, Brian D
Christofi, Fedias L
description ET-1 signalling modulates intestinal motility and inflammation, but the role of ET-1/ET receptor signalling is poorly understood. Enteric glia modulate normal motility and inflammation. We investigated whether glial ET signalling regulates neural-motor pathways of intestinal motility and inflammation. We studied ET signalling using: ET drugs (ET-1, SaTX, BQ788), activity-dependent stimulation of neurons (high K -depolarization, EFS), gliotoxins, Tg (Ednrb-EGFP)EP59Gsat/Mmucd mice, cell-specific mRNA in Sox10 ;Rpl22-HAflx or ChAT ;Rpl22-HAflx mice, Sox10 ::GCaMP5g-tdT, Wnt1 ::GCaMP5g-tdT mice, muscle tension recordings, fluid-induced peristalsis, ET-1 expression, qPCR, western blots, 3-D LSM-immunofluorescence co-labelling studies in LMMP-CM and a postoperative ileus (POI) model of intestinal inflammation. In the muscularis externa ET receptor is expressed exclusively in glia. ET-1 is expressed in RiboTag (ChAT)-neurons, isolated ganglia and intra-ganglionic varicose-nerve fibres co-labelled with peripherin or SP. ET-1 release provides activity-dependent glial ET receptor modulation of Ca waves in neural evoked glial responses. BQ788 reveals amplification of glial and neuronal Ca responses and excitatory cholinergic contractions, sensitive to L-NAME. Gliotoxins disrupt SaTX-induced glial-Ca waves and prevent BQ788 amplification of contractions. The ET receptor is linked to inhibition of contractions and peristalsis. Inflammation causes glial ET up-regulation, SaTX-hypersensitivity and glial amplification of ET signalling. In vivo BQ788 (i.p., 1 mg·kg ) attenuates intestinal inflammation in POI. Enteric glial ET-1/ET signalling provides dual modulation of neural-motor circuits to inhibit motility. It inhibits excitatory cholinergic and stimulates inhibitory nitrergic motor pathways. Amplification of glial ET receptors is linked to muscularis externa inflammation and possibly pathogenic mechanisms of POI.
doi_str_mv 10.1111/bph.16145
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1111_bph_16145</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>37198101</sourcerecordid><originalsourceid>FETCH-LOGICAL-c971-3621a390d3f1decf23f03aeb6638fd69404b5da02e1f33d94bbe9df19ee96a453</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRS0EoqWw4AeQtyxSPHWe7GhVHlIlhNR95MTjxpDGke0U9VP4W1wKzOZqZs48dAm5BjaFEHdV30whhTg5IWOIszRKeA6nZMwYyyKAPB-RC-feGQvNLDknI55BkQODMfmav2V5Ti3uULSOblotWrpc03ko1dh7Y-nWyKEVXpuOGkU7HKzpAlQ3ptUd2o2uqegk7bS3x6wXvvkUe0e9obprdKV9UI_O68Pg1njdar-_pyvdfaA8YL1x3vRow5kdUt3i4C7JmQov4dWvTsj6cblePEer16eXxcMqqosMIp7OQPCCSa5AYq1mXDEusEpTniuZFjGLq0QKNkNQnMsiriospIICsUhFnPAJuT2ura1xzqIqe6u3wu5LYOXB3TK4W_64G9ibI9sP1RblP_lnJ_8Glfp5Cg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>BQ788 reveals glial ET B receptor modulation of neuronal cholinergic and nitrergic pathways to inhibit intestinal motility: Linked to postoperative ileus</title><source>Wiley-Blackwell Open Access Backfiles</source><source>MEDLINE</source><source>Wiley Online Library</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Mazzotta, Elvio ; Grants, Iveta ; Villalobos-Hernandez, Egina ; Chaudhuri, Samhita ; McClain, Jonathon L ; Seguella, Luisa ; Kendig, Derek M ; Blakeney, Bryan A ; Murthy, Srinivasa K ; Schneider, Reiner ; Leven, Patrick ; Wehner, Sven ; Harzman, Alan ; Grider, John R ; Gulbransen, Brian D ; Christofi, Fedias L</creator><creatorcontrib>Mazzotta, Elvio ; Grants, Iveta ; Villalobos-Hernandez, Egina ; Chaudhuri, Samhita ; McClain, Jonathon L ; Seguella, Luisa ; Kendig, Derek M ; Blakeney, Bryan A ; Murthy, Srinivasa K ; Schneider, Reiner ; Leven, Patrick ; Wehner, Sven ; Harzman, Alan ; Grider, John R ; Gulbransen, Brian D ; Christofi, Fedias L</creatorcontrib><description>ET-1 signalling modulates intestinal motility and inflammation, but the role of ET-1/ET receptor signalling is poorly understood. Enteric glia modulate normal motility and inflammation. We investigated whether glial ET signalling regulates neural-motor pathways of intestinal motility and inflammation. We studied ET signalling using: ET drugs (ET-1, SaTX, BQ788), activity-dependent stimulation of neurons (high K -depolarization, EFS), gliotoxins, Tg (Ednrb-EGFP)EP59Gsat/Mmucd mice, cell-specific mRNA in Sox10 ;Rpl22-HAflx or ChAT ;Rpl22-HAflx mice, Sox10 ::GCaMP5g-tdT, Wnt1 ::GCaMP5g-tdT mice, muscle tension recordings, fluid-induced peristalsis, ET-1 expression, qPCR, western blots, 3-D LSM-immunofluorescence co-labelling studies in LMMP-CM and a postoperative ileus (POI) model of intestinal inflammation. In the muscularis externa ET receptor is expressed exclusively in glia. ET-1 is expressed in RiboTag (ChAT)-neurons, isolated ganglia and intra-ganglionic varicose-nerve fibres co-labelled with peripherin or SP. ET-1 release provides activity-dependent glial ET receptor modulation of Ca waves in neural evoked glial responses. BQ788 reveals amplification of glial and neuronal Ca responses and excitatory cholinergic contractions, sensitive to L-NAME. Gliotoxins disrupt SaTX-induced glial-Ca waves and prevent BQ788 amplification of contractions. The ET receptor is linked to inhibition of contractions and peristalsis. Inflammation causes glial ET up-regulation, SaTX-hypersensitivity and glial amplification of ET signalling. In vivo BQ788 (i.p., 1 mg·kg ) attenuates intestinal inflammation in POI. Enteric glial ET-1/ET signalling provides dual modulation of neural-motor circuits to inhibit motility. It inhibits excitatory cholinergic and stimulates inhibitory nitrergic motor pathways. Amplification of glial ET receptors is linked to muscularis externa inflammation and possibly pathogenic mechanisms of POI.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/bph.16145</identifier><identifier>PMID: 37198101</identifier><language>eng</language><publisher>England</publisher><subject>Animals ; Cholinergic Agents - metabolism ; Gastrointestinal Motility ; Gliotoxin - metabolism ; Ileus - drug therapy ; Ileus - etiology ; Ileus - metabolism ; Inflammation - metabolism ; Mice ; Neuroglia ; Neurons - metabolism</subject><ispartof>British journal of pharmacology, 2023-10, Vol.180 (19), p.2550-2576</ispartof><rights>2023 The Authors. British Journal of Pharmacology published by John Wiley &amp; Sons Ltd on behalf of British Pharmacological Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c971-3621a390d3f1decf23f03aeb6638fd69404b5da02e1f33d94bbe9df19ee96a453</citedby><cites>FETCH-LOGICAL-c971-3621a390d3f1decf23f03aeb6638fd69404b5da02e1f33d94bbe9df19ee96a453</cites><orcidid>0000-0003-2773-6846</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37198101$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mazzotta, Elvio</creatorcontrib><creatorcontrib>Grants, Iveta</creatorcontrib><creatorcontrib>Villalobos-Hernandez, Egina</creatorcontrib><creatorcontrib>Chaudhuri, Samhita</creatorcontrib><creatorcontrib>McClain, Jonathon L</creatorcontrib><creatorcontrib>Seguella, Luisa</creatorcontrib><creatorcontrib>Kendig, Derek M</creatorcontrib><creatorcontrib>Blakeney, Bryan A</creatorcontrib><creatorcontrib>Murthy, Srinivasa K</creatorcontrib><creatorcontrib>Schneider, Reiner</creatorcontrib><creatorcontrib>Leven, Patrick</creatorcontrib><creatorcontrib>Wehner, Sven</creatorcontrib><creatorcontrib>Harzman, Alan</creatorcontrib><creatorcontrib>Grider, John R</creatorcontrib><creatorcontrib>Gulbransen, Brian D</creatorcontrib><creatorcontrib>Christofi, Fedias L</creatorcontrib><title>BQ788 reveals glial ET B receptor modulation of neuronal cholinergic and nitrergic pathways to inhibit intestinal motility: Linked to postoperative ileus</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>ET-1 signalling modulates intestinal motility and inflammation, but the role of ET-1/ET receptor signalling is poorly understood. Enteric glia modulate normal motility and inflammation. We investigated whether glial ET signalling regulates neural-motor pathways of intestinal motility and inflammation. We studied ET signalling using: ET drugs (ET-1, SaTX, BQ788), activity-dependent stimulation of neurons (high K -depolarization, EFS), gliotoxins, Tg (Ednrb-EGFP)EP59Gsat/Mmucd mice, cell-specific mRNA in Sox10 ;Rpl22-HAflx or ChAT ;Rpl22-HAflx mice, Sox10 ::GCaMP5g-tdT, Wnt1 ::GCaMP5g-tdT mice, muscle tension recordings, fluid-induced peristalsis, ET-1 expression, qPCR, western blots, 3-D LSM-immunofluorescence co-labelling studies in LMMP-CM and a postoperative ileus (POI) model of intestinal inflammation. In the muscularis externa ET receptor is expressed exclusively in glia. ET-1 is expressed in RiboTag (ChAT)-neurons, isolated ganglia and intra-ganglionic varicose-nerve fibres co-labelled with peripherin or SP. ET-1 release provides activity-dependent glial ET receptor modulation of Ca waves in neural evoked glial responses. BQ788 reveals amplification of glial and neuronal Ca responses and excitatory cholinergic contractions, sensitive to L-NAME. Gliotoxins disrupt SaTX-induced glial-Ca waves and prevent BQ788 amplification of contractions. The ET receptor is linked to inhibition of contractions and peristalsis. Inflammation causes glial ET up-regulation, SaTX-hypersensitivity and glial amplification of ET signalling. In vivo BQ788 (i.p., 1 mg·kg ) attenuates intestinal inflammation in POI. Enteric glial ET-1/ET signalling provides dual modulation of neural-motor circuits to inhibit motility. It inhibits excitatory cholinergic and stimulates inhibitory nitrergic motor pathways. Amplification of glial ET receptors is linked to muscularis externa inflammation and possibly pathogenic mechanisms of POI.</description><subject>Animals</subject><subject>Cholinergic Agents - metabolism</subject><subject>Gastrointestinal Motility</subject><subject>Gliotoxin - metabolism</subject><subject>Ileus - drug therapy</subject><subject>Ileus - etiology</subject><subject>Ileus - metabolism</subject><subject>Inflammation - metabolism</subject><subject>Mice</subject><subject>Neuroglia</subject><subject>Neurons - metabolism</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMtOwzAQRS0EoqWw4AeQtyxSPHWe7GhVHlIlhNR95MTjxpDGke0U9VP4W1wKzOZqZs48dAm5BjaFEHdV30whhTg5IWOIszRKeA6nZMwYyyKAPB-RC-feGQvNLDknI55BkQODMfmav2V5Ti3uULSOblotWrpc03ko1dh7Y-nWyKEVXpuOGkU7HKzpAlQ3ptUd2o2uqegk7bS3x6wXvvkUe0e9obprdKV9UI_O68Pg1njdar-_pyvdfaA8YL1x3vRow5kdUt3i4C7JmQov4dWvTsj6cblePEer16eXxcMqqosMIp7OQPCCSa5AYq1mXDEusEpTniuZFjGLq0QKNkNQnMsiriospIICsUhFnPAJuT2ura1xzqIqe6u3wu5LYOXB3TK4W_64G9ibI9sP1RblP_lnJ_8Glfp5Cg</recordid><startdate>202310</startdate><enddate>202310</enddate><creator>Mazzotta, Elvio</creator><creator>Grants, Iveta</creator><creator>Villalobos-Hernandez, Egina</creator><creator>Chaudhuri, Samhita</creator><creator>McClain, Jonathon L</creator><creator>Seguella, Luisa</creator><creator>Kendig, Derek M</creator><creator>Blakeney, Bryan A</creator><creator>Murthy, Srinivasa K</creator><creator>Schneider, Reiner</creator><creator>Leven, Patrick</creator><creator>Wehner, Sven</creator><creator>Harzman, Alan</creator><creator>Grider, John R</creator><creator>Gulbransen, Brian D</creator><creator>Christofi, Fedias L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-2773-6846</orcidid></search><sort><creationdate>202310</creationdate><title>BQ788 reveals glial ET B receptor modulation of neuronal cholinergic and nitrergic pathways to inhibit intestinal motility: Linked to postoperative ileus</title><author>Mazzotta, Elvio ; Grants, Iveta ; Villalobos-Hernandez, Egina ; Chaudhuri, Samhita ; McClain, Jonathon L ; Seguella, Luisa ; Kendig, Derek M ; Blakeney, Bryan A ; Murthy, Srinivasa K ; Schneider, Reiner ; Leven, Patrick ; Wehner, Sven ; Harzman, Alan ; Grider, John R ; Gulbransen, Brian D ; Christofi, Fedias L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c971-3621a390d3f1decf23f03aeb6638fd69404b5da02e1f33d94bbe9df19ee96a453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Cholinergic Agents - metabolism</topic><topic>Gastrointestinal Motility</topic><topic>Gliotoxin - metabolism</topic><topic>Ileus - drug therapy</topic><topic>Ileus - etiology</topic><topic>Ileus - metabolism</topic><topic>Inflammation - metabolism</topic><topic>Mice</topic><topic>Neuroglia</topic><topic>Neurons - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mazzotta, Elvio</creatorcontrib><creatorcontrib>Grants, Iveta</creatorcontrib><creatorcontrib>Villalobos-Hernandez, Egina</creatorcontrib><creatorcontrib>Chaudhuri, Samhita</creatorcontrib><creatorcontrib>McClain, Jonathon L</creatorcontrib><creatorcontrib>Seguella, Luisa</creatorcontrib><creatorcontrib>Kendig, Derek M</creatorcontrib><creatorcontrib>Blakeney, Bryan A</creatorcontrib><creatorcontrib>Murthy, Srinivasa K</creatorcontrib><creatorcontrib>Schneider, Reiner</creatorcontrib><creatorcontrib>Leven, Patrick</creatorcontrib><creatorcontrib>Wehner, Sven</creatorcontrib><creatorcontrib>Harzman, Alan</creatorcontrib><creatorcontrib>Grider, John R</creatorcontrib><creatorcontrib>Gulbransen, Brian D</creatorcontrib><creatorcontrib>Christofi, Fedias L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mazzotta, Elvio</au><au>Grants, Iveta</au><au>Villalobos-Hernandez, Egina</au><au>Chaudhuri, Samhita</au><au>McClain, Jonathon L</au><au>Seguella, Luisa</au><au>Kendig, Derek M</au><au>Blakeney, Bryan A</au><au>Murthy, Srinivasa K</au><au>Schneider, Reiner</au><au>Leven, Patrick</au><au>Wehner, Sven</au><au>Harzman, Alan</au><au>Grider, John R</au><au>Gulbransen, Brian D</au><au>Christofi, Fedias L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>BQ788 reveals glial ET B receptor modulation of neuronal cholinergic and nitrergic pathways to inhibit intestinal motility: Linked to postoperative ileus</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2023-10</date><risdate>2023</risdate><volume>180</volume><issue>19</issue><spage>2550</spage><epage>2576</epage><pages>2550-2576</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>ET-1 signalling modulates intestinal motility and inflammation, but the role of ET-1/ET receptor signalling is poorly understood. Enteric glia modulate normal motility and inflammation. We investigated whether glial ET signalling regulates neural-motor pathways of intestinal motility and inflammation. We studied ET signalling using: ET drugs (ET-1, SaTX, BQ788), activity-dependent stimulation of neurons (high K -depolarization, EFS), gliotoxins, Tg (Ednrb-EGFP)EP59Gsat/Mmucd mice, cell-specific mRNA in Sox10 ;Rpl22-HAflx or ChAT ;Rpl22-HAflx mice, Sox10 ::GCaMP5g-tdT, Wnt1 ::GCaMP5g-tdT mice, muscle tension recordings, fluid-induced peristalsis, ET-1 expression, qPCR, western blots, 3-D LSM-immunofluorescence co-labelling studies in LMMP-CM and a postoperative ileus (POI) model of intestinal inflammation. In the muscularis externa ET receptor is expressed exclusively in glia. ET-1 is expressed in RiboTag (ChAT)-neurons, isolated ganglia and intra-ganglionic varicose-nerve fibres co-labelled with peripherin or SP. ET-1 release provides activity-dependent glial ET receptor modulation of Ca waves in neural evoked glial responses. BQ788 reveals amplification of glial and neuronal Ca responses and excitatory cholinergic contractions, sensitive to L-NAME. Gliotoxins disrupt SaTX-induced glial-Ca waves and prevent BQ788 amplification of contractions. The ET receptor is linked to inhibition of contractions and peristalsis. Inflammation causes glial ET up-regulation, SaTX-hypersensitivity and glial amplification of ET signalling. In vivo BQ788 (i.p., 1 mg·kg ) attenuates intestinal inflammation in POI. Enteric glial ET-1/ET signalling provides dual modulation of neural-motor circuits to inhibit motility. It inhibits excitatory cholinergic and stimulates inhibitory nitrergic motor pathways. Amplification of glial ET receptors is linked to muscularis externa inflammation and possibly pathogenic mechanisms of POI.</abstract><cop>England</cop><pmid>37198101</pmid><doi>10.1111/bph.16145</doi><tpages>27</tpages><orcidid>https://orcid.org/0000-0003-2773-6846</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2023-10, Vol.180 (19), p.2550-2576
issn 0007-1188
1476-5381
language eng
recordid cdi_crossref_primary_10_1111_bph_16145
source Wiley-Blackwell Open Access Backfiles; MEDLINE; Wiley Online Library; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Animals
Cholinergic Agents - metabolism
Gastrointestinal Motility
Gliotoxin - metabolism
Ileus - drug therapy
Ileus - etiology
Ileus - metabolism
Inflammation - metabolism
Mice
Neuroglia
Neurons - metabolism
title BQ788 reveals glial ET B receptor modulation of neuronal cholinergic and nitrergic pathways to inhibit intestinal motility: Linked to postoperative ileus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T18%3A02%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=BQ788%20reveals%20glial%20ET%20B%20receptor%20modulation%20of%20neuronal%20cholinergic%20and%20nitrergic%20pathways%20to%20inhibit%20intestinal%20motility:%20Linked%20to%20postoperative%20ileus&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Mazzotta,%20Elvio&rft.date=2023-10&rft.volume=180&rft.issue=19&rft.spage=2550&rft.epage=2576&rft.pages=2550-2576&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1111/bph.16145&rft_dat=%3Cpubmed_cross%3E37198101%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/37198101&rfr_iscdi=true